High Grade B-cell Lymphoma (HGBCL)
specificA term that refers to high-grade B-cell lymphoma, not otherwise specified or high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
30
Centers
32
Active Trials
—
Cancer Funding
Top Centers for High Grade B-cell Lymphoma (HGBCL)(30)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 71.2 |
| 2 | Moffitt Cancer CenterTampa, FL NCI Comprehensive High-Volume Research Center | 71.2 |
| 3 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive High-Volume Research Center | 71.2 |
| 4 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical High-Volume Research Center | 71.2 |
| 5 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 50.2 |
| 6 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 50.2 |
| 7 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 50.2 |
| 8 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 50.2 |
| 9 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 50.2 |
| 10 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 50.2 |
| 11 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 50.2 |
| 12 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive Active Research Program | 50.2 |
| 13 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 50.2 |
| 14 | NCI Clinical Active Research Program | 50.2 |
| 15 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 50.2 |
| 16 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.2 |
| 17 | NCI Comprehensive Active Research Program | 50.2 |
| 18 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 50.2 |
| 19 | University of Illinois Cancer CenterChicago, IL Active Research Program | 50.2 |
| 20 | Boston University Cancer CenterBoston, MA Active Research Program | 50.2 |
| 21 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 50.2 |
| 22 | Cancer Center at IllinoisUrbana, IL Active Research Program | 50.2 |
| 23 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 50.2 |
| 24 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 50.2 |
| 25 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 50.2 |
| 26 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 50.2 |
| 27 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 50.2 |
| 28 | Active Research Program | 50.2 |
| 29 | 30.7 | |
| 30 | BC CancerVancouver, BC | 30.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →